U.S. Approves Heart Disease Treatments

Article Abstract:

New Brunswick, NJ-based Johnson and Johnson will compete against Atlanta, Georgia-based Novoste Corp. in selling a newly-approved medical device. The device, which has been approved by the U.S. Food and Drug Administration, slows the growth of scar tissue in the blood vessels of heart disease patients.

Product introduction, Toiletries, Toilet Preparation Manufacturing, Toilet preparations, Toiletries industry, Novoste Corp., NOVT

---

J&J presses Guidant on takeover price

Article Abstract:

Johson & Johnson of the United States is threatening to cancel an acquisition agreement with Guidant Corp. also of the United States if terms can't be renegotiated. Guidant Corp., the medical equipment company, is having problems with a product recall on defibrillators that could effect the longterm financial outlook of the company. The deal is valued at $25.4 billion.

Product standards, safety, & recalls, Acquisitions & mergers, Product defects and recalls, Mergers, acquisitions and divestments, Company acquisition/merger, Guidant Corp., GDT

---

J&J, Boston Scientific report mixed earnings and weak sales

Article Abstract:

Johnson & Johnson of the United States posted slow first quarter revenue increases with net income up by 16 percent to $3.31 billion from $2.84 billion. Revenue was buoyed by sales of medical devices and deal break-up moneys from Guidant Corp. Boston Scientific Corp. also of the United States posted a 7 percent decrease in first quarter profit with costs associated with the Guidant Corp. acquisition.

Sales, profits & dividends, Market share, Company sales and earnings, Company earnings/profit, Company market share, Boston Scientific Corp., Company overview

Similar abstracts:

• Abstracts: Sonera Group's pretax earnings soar 12% on foreign businesses. Sonera's earnings rise 5.6%, helped by mobile business
• Abstracts: Resource allocation to defensive marketing and manufacturing strategies. Marketing-production coordination in channels of distribution
• Abstracts: Medicated skin care (report on retail market in five major countries). The German market for analgesics
• Abstracts: Pressure grows on German banks to restructure amid recession. Commerzbank and Dresdner abandon merger discussions
• Abstracts: Group bidding for De Beers vows $17 billion is its best and last offer. Rio Tinto Raises Ashton Offer And Succeeds With Takeover

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.